Aerpio Pharmaceuticals, Inc.
ARPO · NASDAQ
12/31/2024 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $59,466 | $75,447 | $53,029 | $16,087 |
| - Cash | $28,670 | $14,852 | $10,288 | $9,649 |
| + Debt | $833 | $0 | $0 | $0 |
| Enterprise Value | $31,629 | $60,595 | $42,741 | $6,438 |
| Revenue | $25,983 | $5,508 | $4,474 | $823 |
| % Growth | 371.7% | 23.1% | 443.6% | – |
| Gross Profit | $0 | -$29,509 | -$15,541 | -$13,621 |
| % Margin | 0% | -535.7% | -347.4% | -1,655% |
| EBITDA | -$67,458 | -$36,054 | -$22,653 | -$20,473 |
| % Margin | -259.6% | -654.6% | -506.3% | -2,487.6% |
| Net Income | -$63,691 | -$36,917 | -$23,155 | -$22,181 |
| % Margin | -245.1% | -670.2% | -517.5% | -2,695.1% |
| EPS Diluted | -2.36 | -1.08 | -0.96 | -1.35 |
| % Growth | -118.5% | -12.5% | 28.9% | – |
| Operating Cash Flow | -$59,550 | -$32,481 | -$23,575 | -$18,270 |
| Capital Expenditures | -$1,654 | -$2,211 | -$1,304 | -$824 |
| Free Cash Flow | -$61,204 | -$34,692 | -$24,879 | -$19,094 |